Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc covers the month of March 2026, with the report dated March 16, 2026. Haleon is a consumer health company focused on everyday health, with a portfolio spanning Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. The filing specifically reports on transactions in the company's own shares under its share buyback programme announced on March 12, 2026.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity. Key data points include:
- Total Shares Purchased: 2,749,486 ordinary shares for cancellation.
- Purchase Dates: March 12, 2026, and March 13, 2026.
- Price Range: Highest price paid was 377.80 pence per share; lowest price paid was 369.30 pence per share.
- Volume Weighted Average Price (VWAP): Varied by venue and date, ranging from approximately 373.23 pence to 375.42 pence.
- Share Capital Post-Transaction: 8,949,604,162 ordinary shares of £0.01 each.
- Treasury Shares: 43,651,673 shares held as treasury shares.
- Voting Shares: 8,905,952,489 ordinary shares with voting rights.
Material Changes
The primary material change reported is the reduction in the number of outstanding shares due to the cancellation of 2,749,486 shares purchased under the buyback programme. This action reduces the total share capital and adjusts the count of shares with voting rights. No other material changes to financial position or operations are disclosed in this specific filing.
Guidance, Outlook, and Risks
This filing does not contain updated financial guidance, management commentary on future outlook, or new risk factors. It serves as a regulatory disclosure of share transactions in compliance with the Market Abuse Regulation (EU) No 596/2014 as applied in the UK. The filing notes that a full breakdown of individual trades is available via a provided link and on the company's investor website.
Investor Verification Checklist
- Verify the total number of shares purchased (2,749,486) and the specific dates of execution (March 12-13, 2026).
- Confirm the updated share capital and the number of shares with voting rights (8,905,952,489) for disclosure threshold calculations.
- Review the detailed trade breakdown at the provided London Stock Exchange link for granular pricing and volume data.
- Check the company's website (www.haleon.com/investors) for the full announcement and trade details.